Larson Financial Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Larson Financial Group's BIIB Position: Q3 2026 in Review
Larson Financial Group increased its Biogen (BIIB) stake by 12% in Q3 2026, buying an estimated $24.4K and bringing the position to 1,039 shares worth $235K. The position accounts for 0.01% of the portfolio, ranked #886.
Larson Financial Group first reported a position in BIIB in Q4 2018 and has held it in 24 quarters since. 1,058 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.
- Larson Financial Group held 1,039 shares of Biogen worth $235K as of Q3 2026.
- Larson Financial Group bought 115 Biogen shares in Q3 2026, an estimated $24.4K.
- Biogen made up 0.01% of Larson Financial Group's portfolio in Q3 2026, its #886 holding.
- Larson Financial Group first reported a position in Biogen in Q4 2018 and has held it in 24 quarters since.
- 1,058 funds tracked by Wall St. Rank held Biogen as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.